Tao H - Search Results

1

Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo.

Zuo L, Tao H, Xu H, Li C, Qiao G, Guo M, Cao S, Liu M, Lin X. Zuo L, et al. Among authors: tao h. Drug Des Devel Ther. 2020 Aug 25;14:3495-3507. doi: 10.2147/DDDT.S265423. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32921986 Free PMC article.

2

Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years.

Tao H, Zuo L, Xu H, Li C, Qiao G, Guo M, Lin X. Tao H, et al. Recent Pat Anticancer Drug Discov. 2020;15(1):2-13. doi: 10.2174/1574892815666200131120618. Recent Pat Anticancer Drug Discov. 2020. PMID: 32003702 Review.

3

Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo.

Tao H, Xu H, Zuo L, Li C, Qiao G, Guo M, Zheng L, Leitgeb M, Lin X. Tao H, et al. Int J Biol Macromol. 2020 Oct 15;161:470-480. doi: 10.1016/j.ijbiomac.2020.06.052. Epub 2020 Jun 9. Int J Biol Macromol. 2020. PMID: 32531356

4

Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview.

Wu C, Li W, Tao H, Zhang X, Xin Y, Song R, Wang K, Zuo L, Cai Y, Wu H, Hui W. Wu C, et al. Among authors: tao h. Crit Rev Oncol Hematol. 2024 Jan;193:104195. doi: 10.1016/j.critrevonc.2023.104195. Epub 2023 Nov 4. Crit Rev Oncol Hematol. 2024. PMID: 37931769 Review.

5

Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics.

Tao HY, Zhao CY, Wang Y, Sheng WJ, Zhen YS. Tao HY, et al. Int J Nanomedicine. 2024 Apr 29;19:3805-3825. doi: 10.2147/IJN.S448556. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38708177 Free PMC article. Review.

6

A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer.

He S, Zhao C, Tao H, Sheng W, Gao R, Liu X, Zhen Y. He S, et al. Among authors: tao h. Drug Deliv. 2022 Dec;29(1):1243-1256. doi: 10.1080/10717544.2022.2063454. Drug Deliv. 2022. PMID: 35416106 Free PMC article.

7

The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy.

Tao HY, Wang RQ, Sheng WJ, Zhen YS. Tao HY, et al. Int J Biol Macromol. 2021 Sep 30;187:24-34. doi: 10.1016/j.ijbiomac.2021.07.080. Epub 2021 Jul 17. Int J Biol Macromol. 2021. PMID: 34284054 Review.

8

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach.

Hui W, Song R, Tao H, Gao Z, Zhu M, Zhang M, Wu H, Gong D, Zhang X, Cai Y. Hui W, et al. Among authors: tao h. BMC Cancer. 2023 May 15;23(1):442. doi: 10.1186/s12885-023-10938-8. BMC Cancer. 2023. PMID: 37189081 Free PMC article.

9

Advances in aptamer-mediated targeted delivery system for cancer treatment.

He S, Du Y, Tao H, Duan H. He S, et al. Among authors: tao h. Int J Biol Macromol. 2023 May 31;238:124173. doi: 10.1016/j.ijbiomac.2023.124173. Epub 2023 Mar 23. Int J Biol Macromol. 2023. PMID: 36965552 Review.

10

Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation.

Tao HY, He SM, Zhao CY, Wang Y, Sheng WJ, Zhen YS. Tao HY, et al. Int J Biol Macromol. 2023 Jan 31;226:1088-1099. doi: 10.1016/j.ijbiomac.2022.11.225. Epub 2022 Nov 23. Int J Biol Macromol. 2023. PMID: 36435475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,728 results

Search Page

Filters